Tresoda(Trastuzumab lyophilized powder for IV infusion)
Therapeutic Group: Anti Cancer Presentation TresodaTM 420 Injection: Each vial contains Trastuzumab INN 420 mg as lyophilized cake or powder. Description Trastuzumab is a recombinant humanized monoclonal antibody that selectively targets the extracellular domain of the human epidermal growth factor receptor 2 protein (HER2). Indications • HER2-overexpressing breast cancer. • HER2-overexpressing metastatic gastric or gastroesophageal […]